NervGen Pharma Corp. (NGENF)
USD 2.12
(5.07%)
USD 2.12
(5.07%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -17.77 Million CAD | 22.11% |
| 2022 | -22.82 Million CAD | -77.39% |
| 2021 | -12.86 Million CAD | -15.01% |
| 2020 | -11.18 Million CAD | -13.41% |
| 2019 | -9.86 Million CAD | -626.14% |
| 2018 | -1.35 Million CAD | -11399.9% |
| 2017 | -11.81 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -5 Million CAD | -2.57% |
| 2024 Q2 | -6 Million CAD | -20.01% |
| 2023 Q2 | -4.63 Million CAD | -1.41% |
| 2023 Q1 | -4.57 Million CAD | 31.73% |
| 2023 FY | -17.77 Million CAD | 22.11% |
| 2023 Q3 | -3.27 Million CAD | 29.29% |
| 2023 Q4 | -4.87 Million CAD | -48.65% |
| 2022 FY | -22.82 Million CAD | -77.39% |
| 2022 Q4 | -6.69 Million CAD | -37.84% |
| 2022 Q3 | -4.85 Million CAD | 22.55% |
| 2022 Q2 | -6.27 Million CAD | -24.89% |
| 2022 Q1 | -5.02 Million CAD | -21.54% |
| 2021 Q2 | -2.79 Million CAD | -26.64% |
| 2021 Q1 | -2.2 Million CAD | 48.05% |
| 2021 Q3 | -3.72 Million CAD | -33.32% |
| 2021 Q4 | -4.13 Million CAD | -10.87% |
| 2021 FY | -12.86 Million CAD | -15.01% |
| 2020 FY | -11.18 Million CAD | -13.41% |
| 2020 Q1 | -2.67 Million CAD | 7.83% |
| 2020 Q4 | -4.25 Million CAD | -116.32% |
| 2020 Q3 | -1.96 Million CAD | 14.29% |
| 2020 Q2 | -2.29 Million CAD | 14.4% |
| 2019 Q3 | -2.36 Million CAD | -50.72% |
| 2019 Q4 | -2.9 Million CAD | -22.84% |
| 2019 FY | -9.86 Million CAD | -626.14% |
| 2019 Q2 | -1.56 Million CAD | 41.98% |
| 2019 Q1 | -2.7 Million CAD | -252.23% |
| 2018 Q1 | -10.62 Thousand CAD | -42.51% |
| 2018 Q2 | -64.35 Thousand CAD | -505.7% |
| 2018 FY | -1.35 Million CAD | -11399.9% |
| 2018 Q3 | -515.54 Thousand CAD | -701.15% |
| 2018 Q4 | -767.96 Thousand CAD | -48.96% |
| 2017 FY | -11.81 Thousand CAD | 0.0% |
| 2017 Q3 | -3367.00 CAD | -643.27% |
| 2017 Q4 | -7455.00 CAD | -121.41% |
| 2017 Q2 | -453.00 CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Capstone Therapeutics Corp. | -1.25 Million USD | -1315.343% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 121.718% |
| Nascent Biotech, Inc. | -2.22 Million USD | -697.205% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 67.975% |
| Qrons Inc. | -643.67 Thousand USD | -2661.744% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -4178.606% |
| Adynxx, Inc. | - USD | Infinity% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -252.399% |
| BioStem Technologies, Inc. | -7.77 Million USD | -128.523% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 0.394% |
| Skye Bioscience, Inc. | -13.67 Million USD | -30.025% |
| Rebus Holdings, Inc. | -664 Thousand USD | -2577.215% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -1231.159% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -4463.162% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -12.016% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 75.237% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 461.697% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -6692.107% |
| SQZ Biotechnologies Company | -75.82 Million USD | 76.556% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -523.633% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -1057.301% |
| Mesoblast Limited | -84.14 Million USD | 78.874% |
| Marizyme, Inc. | -34.08 Million USD | 47.848% |
| Genus plc | 6.4 Million USD | 377.761% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 282.466% |
| Pharming Group N.V. | -4.87 Million USD | -264.311% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -794.885% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -1808.642% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -112.895% |
| ContraFect Corporation | -56.88 Million USD | 68.752% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -290.292% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -1167.962% |
| IMV Inc. | -38.67 Million USD | 54.032% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -546.229% |
| MultiCell Technologies, Inc. | -722.81 USD | -2459289.051% |
| ONE Bio Corp. | 13.68 Million USD | 229.932% |
| Accustem Sciences Inc. | -3.74 Million USD | -374.499% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 69.865% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | -3580.006% |
| Q BioMed Inc. | -3.44 Million USD | -415.923% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 602.167% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -576.558% |
| Biomind Labs Inc. | -1 Million USD | -1660.762% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 67.662% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -512.726% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -167.399% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -853.497% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -59250.661% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -819.829% |
| GB Sciences, Inc. | -1.42 Million USD | -1151.432% |
| Alpha Cognition Inc. | -9.7 Million USD | -83.159% |
| HST Global, Inc. | -140.9 Thousand USD | -12515.917% |
| CSL Limited | 3.7 Billion USD | 100.48% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -1480.284% |
| Halberd Corporation | -75.05 Thousand USD | -23586.489% |
| Enzolytics Inc. | -2.14 Million USD | -727.285% |
| Agentix Corp. | -1.37 Million USD | -1195.909% |
| Resverlogix Corp. | -12.74 Million USD | -39.436% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -461.085% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -425.04 Million USD | 95.818% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -1602.75% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -508.907% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -1025.568% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -422.08% |
| AVAX Technologies, Inc. | 6.69 Million USD | 365.606% |
| Zenith Capital Corp. | -8.94 Million USD | -98.778% |
| Genscript Biotech Corporation | -415.79 Million USD | 95.725% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -101941.846% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -624.009% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -10264.852% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -786.726% |
| Kadimastem Ltd | -3.04 Million USD | -484.712% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -1706.479% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -9695.14% |
| LadRx Corporation | -3.82 Million USD | -364.918% |
| Cell Source, Inc. | -4.32 Million USD | -310.989% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -2487.773% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -2487.773% |
| NovAccess Global Inc. | -2.46 Million USD | -620.65% |
| Affymax, Inc. | -15.04 Million USD | -18.149% |
| Itoco Inc. | -919.14 Thousand USD | -1834.059% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -319.419% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -1488.625% |
| Mobile Lads Corp. | -554.55 Thousand USD | -3105.61% |
| CytoDyn Inc. | -18.05 Million USD | 1.558% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -70526.579% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -7977.459% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -3047.864% |
| SYBLEU INC | -149.18 Thousand USD | -11816.282% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -878.721% |
| International Stem Cell Corporation | -663 Thousand USD | -2581.253% |
| Bioxytran, Inc. | -3.82 Million USD | -365.341% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -33670.346% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -87297.788% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 50.982% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -998.684% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -2315.855% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -471.415% |
| Neutra Corp. | -229.48 Thousand USD | -7646.316% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -1.355% |
| PureTech Health plc | -146.19 Million USD | 87.841% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 17.283% |
| IXICO plc | -1.43 Million USD | -1137.071% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -87.301% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 85.406% |
| CSL Limited | 3.81 Billion USD | 100.466% |
| Cellectis S.A. | -108.85 Million USD | 83.67% |